Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels

NCT06939751 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT06939751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06939751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
Lead sponsor
Northwestern University
Phase
Observational
Overall status
Recruiting
Start date
October 28, 2025
Completion date
January 1, 2032
Enrollment
250 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac failure, graft rejection